- Home
- SAFT vs ELVN Comparison
SAFT vs ELVN Comparison
Compare SAFT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFT
- ELVN
- Stock Information
- Founded
- SAFT 1979
- ELVN 2016
- Country
- SAFT United States
- ELVN United States
- Employees
- SAFT N/A
- ELVN N/A
- Industry
- SAFT Property-Casualty Insurers
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- SAFT Finance
- ELVN Health Care
- Exchange
- SAFT Nasdaq
- ELVN Nasdaq
- Market Cap
- SAFT 1.0B
- ELVN 1.2B
- IPO Year
- SAFT N/A
- ELVN 2020
- Fundamental
- Price
- SAFT $68.93
- ELVN $21.55
- Analyst Decision
- SAFT
- ELVN Strong Buy
- Analyst Count
- SAFT 0
- ELVN 5
- Target Price
- SAFT N/A
- ELVN $41.20
- AVG Volume (30 Days)
- SAFT 62.4K
- ELVN 411.0K
- Earning Date
- SAFT 10-28-2025
- ELVN 11-12-2025
- Dividend Yield
- SAFT 5.34%
- ELVN N/A
- EPS Growth
- SAFT 65.99
- ELVN N/A
- EPS
- SAFT 5.73
- ELVN N/A
- Revenue
- SAFT $1,199,774,000.00
- ELVN N/A
- Revenue This Year
- SAFT N/A
- ELVN N/A
- Revenue Next Year
- SAFT N/A
- ELVN $20.05
- P/E Ratio
- SAFT $12.03
- ELVN N/A
- Revenue Growth
- SAFT 16.96
- ELVN N/A
- 52 Week Low
- SAFT $67.82
- ELVN $13.30
- 52 Week High
- SAFT $90.00
- ELVN $29.79
- Technical
- Relative Strength Index (RSI)
- SAFT 40.85
- ELVN 56.37
- Support Level
- SAFT $68.98
- ELVN $20.10
- Resistance Level
- SAFT $70.49
- ELVN $21.88
- Average True Range (ATR)
- SAFT 1.23
- ELVN 1.00
- MACD
- SAFT 0.07
- ELVN 0.01
- Stochastic Oscillator
- SAFT 41.57
- ELVN 64.44
About SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.